Kewaunee Scientific Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024
For the nine months, sales was USD 147.05 million compared to USD 165.51 million a year ago. Net income was USD 7.73 million compared to net loss of USD 0.267 million a year ago. Basic earnings per share from continuing operations was USD 2.68 compared to basic loss per share from continuing operations of USD 0.09 a year ago. Diluted earnings per share from continuing operations was USD 2.64 compared to diluted loss per share from continuing operations of USD 0.09 a year ago.